Dealing naturally with stumbling blocks on highways and byways of TRAIL induced signaling

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 19, 2014, Pages 8041-8046

  Rana, Aamir ^a   Attar, Rukset ^b   Qureshi, Muhammad Zahid ^c   Gasparri, Maria Luisa ^d   Di Donato, Violante ^d   Ali, Ghulam Muhammad ^a   Farooqi, Ammad Ahmad ^e  

^a NATIONAL AGRICULTURAL RESEARCH CENTRE   (Pakistan)

^b YEDITEPE UNIVERSITY   (Turkey)

^c GCU   (Pakistan)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e RASHID LATIF MEDICAL COLLEGE   (Pakistan)

Author keywords

Apoptosis; Coumarin; Piperlogumine; Signaling; TRAIL

Indexed keywords

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL; APOPTOSIS; DRUG RESISTANCE; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84908374979     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.19.8041     Document Type: Short Survey

References (47)

1. Aras A, Khokhar AR, Qureshi MZ, et al. (2014). Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets. Asian Pac J Cancer Prev, 15, 3865-71.
2. Arbab IA, Looi CY, Abdul AB ,et al. (2012). Dentatin induces apoptosis in prostate cancer cells via Bcl-2, Bcl-xL, survivin downregulation, Caspase-9, -3/7 Activation, and NF-κB inhibition. Evid Based Complement Alternat Med, 2012, 856029.
3. Bana E, Sibille E, Valente S, et al. (2013). A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death. Mol Carcinog.
4. Bharadwaj U, Eckols TK, Kolosov M, et al. (2014). Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene, [Epub ahead of print].
5. Bronikowska J, Szliszka E, Jaworska D, et al. (2012). The coumarin psoralidin enhances anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Molecules, 17, 6449-64.
6. Di X, Zhang G, Zhang Y, et al. (2013). Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5. Oncotarget, 4, 1349-64.
7. Gholami O, Jeddi-Tehrani M, Iranshahi M, et al. (2013). Umbelliprenin from Ferula szowitsiana Activates both intrinsic and extrinsic pathways of apoptosis in jurkat T-CLL cell line. Iran J Pharm Res, 12, 371-6.
8. Ginzburg S1, Golovine KV, Makhov PB, et al. (2014). Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells. Prostate, 74, 177-86.
9. Gong LH, Chen XX, Wang H, et al. (2014). Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells. Oxid Med Cell Longev, 2014, 906804.
10. Haghighi F, Matin MM, Bahrami AR, et al. (2014). The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage. Daru, 22, 3.
11. Haghighitalab A, Matin MM, Bahrami AR, et al. (2014). In vitro investigation of anticancer, cell-cycle-inhibitory, and apoptosis-inducing effects of diversin, a natural prenylated coumarin, on bladder carcinoma cells. Z Naturforsch, 69, 99-109.
12. Ham S, Kim KH, Kwon TH, et al. (2014). Luteolin induces intrinsic apoptosis via inhibition of E6/E7 oncogenes and activation of extrinsic and intrinsic signaling pathways in HPV-18-associated cells. Oncol Rep, 31, 2683-91.
13. Han SS, Tompkins VS, Son DJ, et al. (2013). Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells. Biochem Biophys Res Commun, 436, 660-5.
14. He W, Wang Q, Xu J, et al. (2012). Attenuation of TNFSF10/ TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation. Autophagy, 8, 1811-21.
15. Huang T, Gong WH, Li XC, et al. (2012). Oxaliplatin sensitizes OS cells to TRAIL-induced apoptosis via down-regulation of Mcl1. Asian Pac J Cancer Prev, 13, 3477-81.
16. Huong LD, Shin JA, Choi ES, et al. (2012). β-Phenethyl isothiocyanate induces death receptor 5 to induce apoptosis in human oral cancer cells via p38. Oral Dis, 18, 513-9.
17. Huong le D, Shim JH, Choi KH, et al. (2011). Effect of β-phenylethyl isothiocyanate from cruciferous vegetables on growth inhibition and apoptosis of cervical cancer cells through the induction of death receptors 4 and 5. J Agric Food Chem, 59, 8124-31.
18. Jiang L, Hao JL, Jin ML, et al. (2013). Effect of embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells. Asian Pac J Cancer Prev, 14, 6115-20.
19. Jin HO, Lee YH, Park JA, et al. (2014). Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells. J Cancer Res Clin Oncol, [Epub ahead of print].
20. Jin SM, Jang HW, Sohn SY, et al. (2014). Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells. Endocrine, 45, 256-62.
21. Kim JK, Kim JY, Kim HJ, et al. (2013). Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity. PLoS One, 8, 80391.
22. Kok SH, Yeh CC, Chen ML, et al. (2009). Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells. Oral Oncol, 45, 1067-72.
23. Lee DH, Kim DW, Lee HC, et al. (2014). Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis. Biochem Biophys Res Commun, 446, 815-21.
24. Lee SY, Lim TG, Chen H (2013). Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-catenin. Cancer Prev Res, 6, 1356-64.
25. Li X, Zeng X, Sun J, et al. (2014). Imperatorin induces Mcl-1 degradation to cooperatively trigger Bax translocation and Bak activation to suppress drug-resistant human hepatoma. Cancer Lett, 348, 146-55.
26. Lin MH, Cheng CH, Chen KC, et al. (2014). Induction of ROS-independent JNK-activation-mediated apoptosis by a novel coumarin-derivative, DMAC, in human colon cancer cells. Chem Biol Interact, 218, 42-9.
27. Liu JM, Pan F, Li L, et al. (2013). Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem Biophys Res Commun, 437, 87-93.
28. Liu X, Chen L, Sun F, Zhang G (2013). Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin- 3-carboxylic acid and its molecular mechanisms of action. Cytotechnology, 65, 597-608.
29. Makhov P, Golovine K, Teper E, et al. (2014). Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death. Br J Cancer, 110, 899-907.
30. Musa MA, Badisa VL, Latinwo LM (2012) Coumarin-based benzopyranone derivatives induced apoptosis in human lung (A549) cancer cells. Anticancer Res, 32, 4271-6.
31. Nasr T, Bondock S, Youns M. (2014). Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eur J Med Chem, 76, 539-48.
32. Niu TK, Cheng Y, Ren X, Yang JM (2010). Interaction of beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis. FEBS Lett, 584, 3519-24.
33. Ou YC, Li JR, Kuan YH, et al. (2014). Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis. Life Sci, 100, 110-7.
34. Randhawa H, Kibble K, Zeng H, et al. (2013). Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicol In Vitro, 27, 1626-33.
35. Sehitoglu MH, Farooqi AA, Qureshi MZ, et al. (2014). Anthocyanins: targeting of signaling networks in cancer cells. Asian Pac J Cancer Prev, 15, 2379-81.
36. Shrivastava S, Kulkarni P, Thummuri D, et al. (2014). Piperlongumine, an alkaloid causes inhibition of PI3K/Akt/ mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells. Apoptosis, 19, 1148-64.
37. Silva MF, Khokhar AR, Qureshi MZ, Farooqi AA. (2014). Ionizing radiations induce apoptosis in TRAIL resistant cancer cells: in vivo and in vitro analysis. Asian Pac J Cancer Prev, 15, 1905-7.
38. Singh N, Sarkar J, Sashidhara KV, et al. (2014). Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio. Apoptosis, 19, 1017-28.
39. Szliszka E, Czuba ZP, Sedek L, et al. (2011). Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia. Pharmacol Rep, 63, 139-48.
40. van Roosmalen IA, Quax WJ, Kruyt FA (2014).Two death-inducing human TRAIL receptors to target in cancer: similar or distinct regulation and function? Biochem Pharmacol, 14, 465-1.
41. Vijay Avin BR, Thirusangu P, Lakshmi Ranganatha V, et al. (2014). Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis. Eur J Med Chem, 75, 211-21.
42. Wang D, Upadhyaya B, Liu Y, et al. (2014). Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells. BMC Cancer, 14, 591.
43. Yan J, Wang Q, Zheng X, et al. (2012). Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model. Biochem Biophys Res Commun, 417, 842-6.
44. Yao JX, Yao ZF, Li ZF, Liu YB (2014). Radio-sensitization by piper longumine of human breast adenoma MDA-MB-231 cells in Vitro. Asian Pac J Cancer Prev, 15, 3211-7.
45. Zhang L, Jiang G, Yao F (2012). Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma. PLoS One, 7, 37865.
46. Zhang W, Li Z, Zhou M (2014). Synthesis and biological evaluation of 4-(1, 2, 3-triazol-1-yl) coumarin derivatives as potential antitumor agents. Bioorg Med Chem Lett, 24, 799-807.
47. Zhao B, Li L, Cui K, et al. (2011). Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis. Asian Pac J Cancer Prev, 12, 2675-8.